Medication Assisted Conspiracy –

July 11, 2019 – “Opioid withdrawal is difficult, painful, and sometimes dangerous; people struggling to overcome addiction face challenges that can often seem insurmountable,” the Assistant Attorney General Jody Hunt for the Department of Justice’s Civil Division said in a statement. “Drug manufacturers marketing products to help opioid addicts are expected to do so honestly and responsibly … Suboxone, which proved to be a blockbuster-selling drug for Indivior, is an addiction-fighting medication that also contains opioids. Indivior was spun off into a separate company from the RB Group in December 2014, but the exposure and looming litigation and probes related to Suboxone were still attached to the parent company. On April 9, a federal grand jury in Virginia indicted Indivior for “allegedly engaging in an illicit nationwide scheme to increase prescriptions of Suboxone,” according to the DOJ. The company denied the charges and trial is scheduled to start in May 2020.

Full Story @ ABCNews.com